The American College of Rheumatology, along with the American Board of Internal Medicine Foundation and Consumer Reports, released 5 suggestions as part of the Choosing Wisely campaign. Choosing Wisely is an initiative that encourages doctors and patients to consider which medical tests and procedures may be unnecessary, or possibly even harmful. Read more...
The use of glucocorticoids (steroids) is associated with an increased risk of venous thromboembolism (blood clots). Venous thromboembolism includes both deep vein thrombosis and pulmonary embolism. Read more...
Rheumatoid arthritis is less common in men than women. It has been suggested that sex hormones play some role in the development of rheumatoid arthritis. Men with rheumatoid arthritis tend to have lower levels of testosterone than men without the disease. Read more...
If you are a person who likes to follow what's in the pipeline for arthritis, you likely know that AstraZeneca has been developing fostamatinib for rheumatoid arthritis. In the OSKIRA-1 Phase III study, fostamatinib achieved only one of two goals. Read more...
Sign up for more free newsletters on your favorite topics
You are receiving this newsletter because you subscribed to the About.com Arthritis & Joint Conditions newsletter. If you wish to change your email address or unsubscribe, please click here.
The American College of Rheumatology, along with the American Board of Internal Medicine Foundation and Consumer Reports, released 5 suggestions as part of the Choosing Wisely campaign. Choosing Wisely is an initiative that encourages doctors and patients to consider which medical tests and procedures may be unnecessary, or possibly even harmful. 
The use of glucocorticoids (steroids) is associated with an increased risk of venous thromboembolism (blood clots). Venous thromboembolism includes both deep vein thrombosis and pulmonary embolism. 
Rheumatoid arthritis is less common in men than women. It has been suggested that sex hormones play some role in the development of rheumatoid arthritis. Men with rheumatoid arthritis tend to have lower levels of testosterone than men without the disease. 
If you are a person who likes to follow what's in the pipeline for arthritis, you likely know that AstraZeneca has been developing fostamatinib for rheumatoid arthritis. In the OSKIRA-1 Phase III study, fostamatinib achieved only one of two goals. 
Nema komentara:
Objavi komentar